formestane

Other names: 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol, 4-hydroxy-androst-4-ene-3,17-dione, 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5alpha-androstan-17beta-ol, 4-hydroxy-Δ(sub 4)-androstenedione, 4-hydroxyandrost-4-ene-3,17-dione, 4-OH-A, CGP 32 349, 4-OHA, 4-hydroxyandrostenedione, 4-hydroxy-4-androstene-3,17-dione, Lentaron, CGP-32349, NSC 282175, CGP 32349, CCRIS 7483, 4-hydroxyandrostene-3,17-dione, 4-hydroxy-delta(sub 4)-androstenedione, BRN 1889793

Classifications: 6000

Reasons for prohibition: - DEA Controlled Substance List: Schedule III (source) - WADA S4: Hormone and Metabolic Modulators (source) - Unapproved Drug

References: - {'title': 'NIH NCATS Inxight Drugs entry: Formestane', 'url': 'https://drugs.ncats.io/drug/PUB9T8T355'}

Reason: Controlled substance: Schedule III; WADA S4: Hormone and Metabolic ModulatorsUnapproved drug

Label terms: []

Searchable name: formestane

GUID: 3f512445-4025-4845-b757-a7b429df845b

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1738953485, "_nanoseconds": 550000000}